NVCT
Price
$5.97
Change
-$0.08 (-1.32%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
152.92M
110 days until earnings call
Intraday BUY SELL Signals
PDSB
Price
$0.75
Change
-$0.04 (-5.06%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
41.04M
127 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NVCT vs PDSB

Header iconNVCT vs PDSB Comparison
Open Charts NVCT vs PDSBBanner chart's image
Nuvectis Pharma
Price$5.97
Change-$0.08 (-1.32%)
Volume$600
Capitalization152.92M
PDS Biotechnology
Price$0.75
Change-$0.04 (-5.06%)
Volume$8.17K
Capitalization41.04M
NVCT vs PDSB Comparison Chart in %
NVCT
Daily Signal:
Gain/Loss:
PDSB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NVCT vs. PDSB commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVCT is a Hold and PDSB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (NVCT: $6.06 vs. PDSB: $0.79)
Brand notoriety: NVCT and PDSB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVCT: 74% vs. PDSB: 57%
Market capitalization -- NVCT: $152.92M vs. PDSB: $41.04M
NVCT [@Biotechnology] is valued at $152.92M. PDSB’s [@Biotechnology] market capitalization is $41.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVCT’s FA Score shows that 0 FA rating(s) are green whilePDSB’s FA Score has 0 green FA rating(s).

  • NVCT’s FA Score: 0 green, 5 red.
  • PDSB’s FA Score: 0 green, 5 red.
According to our system of comparison, NVCT is a better buy in the long-term than PDSB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVCT’s TA Score shows that 4 TA indicator(s) are bullish while PDSB’s TA Score has 4 bullish TA indicator(s).

  • NVCT’s TA Score: 4 bullish, 5 bearish.
  • PDSB’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both NVCT and PDSB are a bad buy in the short-term.

Price Growth

NVCT (@Biotechnology) experienced а 0.00% price change this week, while PDSB (@Biotechnology) price change was -25.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

NVCT is expected to report earnings on Mar 10, 2026.

PDSB is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCT($153M) has a higher market cap than PDSB($41M). NVCT YTD gains are higher at: 10.351 vs. PDSB (-51.601). NVCT has higher annual earnings (EBITDA): -22.97M vs. PDSB (-32.36M). PDSB has more cash in the bank: 31.9M vs. NVCT (26.8M). NVCT (0) and PDSB (0) have equivalent revenues.
NVCTPDSBNVCT / PDSB
Capitalization153M41M373%
EBITDA-22.97M-32.36M71%
Gain YTD10.351-51.601-20%
P/E RatioN/AN/A-
Revenue00-
Total Cash26.8M31.9M84%
Total DebtN/A18.5M-
FUNDAMENTALS RATINGS
PDSB: Fundamental Ratings
PDSB
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVCTPDSB
RSI
ODDS (%)
N/A
Bullish Trend 6 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
NVCT
Daily Signal:
Gain/Loss:
PDSB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMNXF3.450.07
+2.07%
Perseus Mining Ltd
BCCEF0.03N/A
N/A
BacTech Environmental Corporation
OPNDF3.00N/A
N/A
Open Door Inc.
LUOYF0.58N/A
N/A
LUOYANG GLASS COMPANY LTD.
GBERF733.49-30.37
-3.98%
Geberit AG

NVCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCT has been loosely correlated with PDSB. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCT jumps, then PDSB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
-1.32%
PDSB - NVCT
35%
Loosely correlated
-4.93%
MRVI - NVCT
32%
Poorly correlated
-3.18%
SGMT - NVCT
31%
Poorly correlated
+0.51%
ADMA - NVCT
30%
Poorly correlated
+1.69%
AVBP - NVCT
28%
Poorly correlated
-0.74%
More